Home > Formulary : Adult > Recent Decisions > 2015 >
Decisions 2nd June 2015
At the meeting that took place on 2nd June, the following decisions were agreed:
New Drug Requests
Approved
Tocilizumab monotherapy (TLS Red)
- Approved for inclusion onto the formulary for adults with moderate/severe, active rheumatoid arthritis who cannot take methotrexate.
Abatacept subcutaneous (TLS Red)
- Approved for inclusion onto the formulary for adults with moderate/severe, active rheumatoid arthritis, in combination with methotrexate, in accordance with NICE TAs 195 and 280.
Rituximab in combination with Leflunomide (TLS Red)
- Approved for inclusion onto the formulary for adults with severe, active rheumatoid arthritis who cannot take methotrexate and who have had inadequate response or intolerance to other DMARDs and one or more anti-TNF therapies.
More information required
Simbrinza® (Brinzolamide & Brimonidine)
- Information regarding current prescribing trends and generic availability required
Other decisions
Wound Care Formularies
- Each organisations version of the PAN AVON Wound care formulary is/will be included on the BNSSG Formulary Website.